agilon health’s (AGL) “Sell” Rating Reiterated at Citigroup
MarketBeatCitigroup reaffirmed a “sell” rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday.
Citigroup reaffirmed a “sell” rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday.
